Evaluation of relationships between hepatic steatosis and sleep apnea in subjects suspected to have abdominal obesity, and effects of CPAP treatment on hepatic steatosis.
Not Applicable
- Conditions
- obstructive sleep apnea, hepatic steatosis
- Registration Number
- JPRN-UMIN000007112
- Lead Sponsor
- Kyoto University Graduate School of Medicine, Department of respiratory medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Male
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
# Those who have positive serological HBs antigen, positive serological HCV antibody, or liver disease other than fatty liver. # Those who have other serious complications. # Those whose blood BNP levels are 100pg/ml or more. # Those who take drugs which may cause of hepatic steatosis (amiodarone, methotrexate, systemic steroids, etc.)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method CT attenuation of liver
- Secondary Outcome Measures
Name Time Method